Aurobindo Pharma (Aurobindo Pharma) Change In Receivables : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Aurobindo Pharma Change In Receivables?

Aurobindo Pharma's change in receivables for the quarter that ended in Mar. 2024 was $0.00 Mil. It means Aurobindo Pharma's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Aurobindo Pharma's change in receivables for the fiscal year that ended in Mar. 2024 was $-31.91 Mil. It means Aurobindo Pharma's Accounts Receivable increased by $31.91 Mil from Mar. 2023 to Mar. 2024 .

Aurobindo Pharma's Accounts Receivable for the quarter that ended in Mar. 2024 was $580.18 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aurobindo Pharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.67.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aurobindo Pharma's liquidation value for the three months ended in Mar. 2024 was $-13.50 Mil.

Aurobindo Pharma Change In Receivables Historical Data

The historical data trend for Aurobindo Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Change In Receivables Chart

Aurobindo Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-88.39

101.64

-53.59

-52.40

-31.91

Aurobindo Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Aurobindo Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Aurobindo Pharma (GREY:ARBQY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aurobindo Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	580.181	/	902.408	*	91
=	58.67

2. In Ben Graham's calculation of liquidation value, Aurobindo Pharma's accounts receivable are only considered to be worth 75% of book value:

Aurobindo Pharma's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	794.011	-	1833.348	+	0.75 * 580.181	+	0.5 * 1181.41
=	-13.50

Aurobindo Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma (Aurobindo Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (GREY:ARBQY) » Definitions » Change In Receivables

Traded in Other Exchanges

AUROPHARMA:India 524804:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (Aurobindo Pharma) Headlines

From GuruFocus

Aurobindo Pharma Wins Company of the Year and Acquisition of the Year Awards at the Global Generics & Biosimilars Awards 2019

By PRNewswire PRNewswire • 11-21-2019